Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
12/20/2001 | US20010053539 Polypeptide for use in the diagnosis and treatment of blood, kidney and live disoders |
12/20/2001 | US20010053538 Biologically active synthetic thyrotropin and cloned gene for producing same |
12/20/2001 | US20010053536 cDNA clone HDPBI30 that encodes a novel human 7-transmembrane receptor |
12/20/2001 | US20010053533 Detecting infectious protein in solution; prepare solution composed from body fluid or fluidized organ expose to chromatographic column, detect infectious protein |
12/20/2001 | US20010053357 Peptide having an amino acid sequence corresponding to an amino acid sequence of a V-domain of a receptor for advanced glycation endproduct. |
12/20/2001 | DE10027383A1 Nukleinsäure-Molekül umfassend eine für ein Chemokin, einen Neuropeptid-Präkursor oder mindestens ein Neuropeptid kodierende Nukleinsäuresequenz Nucleic acid molecule comprising a sequence coding for a chemokine, a neuropeptide precursor or at least one neuropeptide nucleic acid sequence |
12/20/2001 | CA2413003A1 Immunoassays for anti-hcv antibodies |
12/20/2001 | CA2412665A1 Scramblase 2 |
12/20/2001 | CA2412663A1 A human homologue of the dbf4/ask1 protein, nucleic acids, and methods related to the same |
12/20/2001 | CA2412521A1 Thyrotropin-releasing hormone receptor-like gpcr (gprfwki) |
12/20/2001 | CA2412257A1 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
12/20/2001 | CA2410610A1 Human kinases |
12/20/2001 | CA2410604A1 Use of coiled-coil structural scaffold to generate structure-specific peptides |
12/20/2001 | CA2410532A1 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
12/20/2001 | CA2410229A1 Vaccine for congenital tremors in pigs |
12/20/2001 | CA2409315A1 Protein phosphatases |
12/19/2001 | EP1163911A1 Glycoconjugates obtained from candida utilis cells and ricinus communis seeds |
12/19/2001 | EP1163524A2 Methods of screening for colorectal cancer modulators |
12/19/2001 | EP1163522A1 Method for detecting superantigen activity in a biological sample |
12/19/2001 | EP1163347A2 Zwittermicin a biosynthetic gene from bacillus cereus |
12/19/2001 | EP1163346A1 Hybrid synthetase, hybrid peptide and composition containing same |
12/19/2001 | EP1163344A1 Hyphal growth in fungi |
12/19/2001 | EP1163342A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
12/19/2001 | EP1163338A2 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS |
12/19/2001 | EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof |
12/19/2001 | EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION |
12/19/2001 | EP1163332A1 48 human secreted proteins |
12/19/2001 | EP1163331A1 50 human secreted proteins |
12/19/2001 | EP1163325A1 Expression of proteolytic enzymes in koji mold in the presence of carbon sources |
12/19/2001 | EP1163272A1 Antibodies specific for cyp1b1 |
12/19/2001 | EP1163271A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders |
12/19/2001 | EP1163267A1 47 human secreted proteins |
12/19/2001 | EP1163266A2 Barley gene for thioredoxin and nadp-thioredoxin reductase |
12/19/2001 | EP1163260A1 Process for partitioning of proteins |
12/19/2001 | EP1163255A1 50 human secreted proteins |
12/19/2001 | EP1162997A2 Staphylococcus antigen and vaccine |
12/19/2001 | EP1001990A4 Protein that binds trail |
12/19/2001 | EP0726942B1 Monoclonal antibodies to foam cells and their pharmaceutical and diagnostic use |
12/19/2001 | EP0701570B1 Thermoresistant alpha-1-antitrypsin mutein |
12/19/2001 | EP0666866B1 Method of isolating biomolecules by ion exchange |
12/19/2001 | EP0623215B1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
12/19/2001 | CN1327452A Fibroblast growth factor with hepatocyte proliferation activity |
12/19/2001 | CN1327449A Human cervical cancer 1 protooncogene and protein encoded therein |
12/19/2001 | CN1327069A Process for extracting amino acid polypeptide with animal bone marrow and tissue |
12/19/2001 | CN1326782A About human digestive enzyme recombined protein and its preparing method |
12/19/2001 | CN1076356C Protein having TPO activity |
12/19/2001 | CN1076204C Recombinant coccidiosis vaccines |
12/18/2001 | US6331621 Nucleotide sequences coding protein with enzymatic activity; for use in treatment of glomeronephritis, fibrosis, cirrhosis, cancer and arthritis |
12/18/2001 | US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand) |
12/18/2001 | US6331613 Nucleotide sequences coding protein associated with cytokine activity; for use in treating allergies, autoimmune diseases and acquired immune deficiency syndrome; for preventing cell differentiation; for activating tissue regeneration |
12/18/2001 | US6331612 Bone morphogenic protein-16 (BMP-16) compositions |
12/18/2001 | US6331609 Fusion protein; for use in treatment of somatotropin defects |
12/18/2001 | US6331522 Antibacterial and antifungal peptide |
12/18/2001 | US6331521 Beta-1,3-glucan synthase inhibitors; pneumocystis pneumonia infection treatment; fungicides |
12/18/2001 | US6331433 Human T cell leukemia cell line designated D1.1 |
12/18/2001 | US6331415 Methods of producing immunoglobulins, vectors and transformed host cells for use therein |
12/18/2001 | US6331414 Preparation of human IGF via recombinant DNA technology |
12/18/2001 | US6331411 TopA |
12/18/2001 | US6331410 Polynucleotides encoding a novel pyrR homolog |
12/18/2001 | US6331301 Isolated dna sequences which encodes amino acid sequence in protein; |
12/18/2001 | CA2215531C Mutant of the erythrina caffra type inhibitor and the use of the said mutant for purifying serin proteases |
12/18/2001 | CA2209298C Mpl ligand analogs |
12/18/2001 | CA2201762C Method for purifying keratinocyte growth factors |
12/13/2001 | WO2001094645A1 Two-hybrid assay that detects hiv-1 reverse transcriptase dimerization |
12/13/2001 | WO2001094587A2 Extracellular messengers |
12/13/2001 | WO2001094585A1 Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
12/13/2001 | WO2001094580A1 Novel g-protein coupled receptor |
12/13/2001 | WO2001094548A2 Hy2 family of bilin reductases |
12/13/2001 | WO2001094544A2 N.bstnbi nicking endonuclease and methods for using endonucleases in single-stranded displacement amplification |
12/13/2001 | WO2001094418A2 Leader peptides for enhancing secretion of recombinant protein from a host cell |
12/13/2001 | WO2001094415A2 Nuclear hormone receptor |
12/13/2001 | WO2001094414A2 THE HUMAN VOLTAGE GATED SODIUM CHANNEL β-1A SUBUNIT AND METHODS OF USE |
12/13/2001 | WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
12/13/2001 | WO2001094391A2 Intracellular signaling proteins |
12/13/2001 | WO2001093983A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | WO2001093892A1 Methods and compositions for inhibiting immunoglobulin-mediated__reperfusion injury |
12/13/2001 | WO2001093805A2 FUSION OF jAZF1 AND jjAZ1 GENES IN ENDOMETIRIAL STROMAL TUMORS |
12/13/2001 | WO2001072772A3 Calcium binding regulatory subunit |
12/13/2001 | WO2001070968A3 Production of recombinant blood clotting factors in human cell lines |
12/13/2001 | WO2001030987A3 Tankyrase h, compositions involved in the cell cycle and methods of use |
12/13/2001 | WO2001020026A3 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
12/13/2001 | WO2000032773A9 Compositions and methods for increasing bone mineralization |
12/13/2001 | WO2000015845A9 T-type calcium channel |
12/13/2001 | WO2000008043A9 Prevention and treatment of viral disease |
12/13/2001 | US20010051372 Monoclonal immunoglublin; for use in gene therapy and cell transplantation |
12/13/2001 | US20010051361 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
12/13/2001 | CA2707766A1 Plasmids ptqomp and ptto-1 which have an ompa signal sequence |
12/13/2001 | CA2594659A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2591930A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2591929A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2591814A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2591656A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2591590A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2591583A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/13/2001 | CA2412386A1 Two-hybrid assay that detects hiv-1 reverse transcriptase dimerization |
12/13/2001 | CA2412382A1 Hy2 family of bilin reductases |
12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
12/13/2001 | CA2412374A1 Novel leader peptides for enhancing secretion of recombinant protein from a host cell |
12/13/2001 | CA2411719A1 Novel g-protein coupled receptor |
12/13/2001 | CA2411069A1 The human voltage gated sodium channel .beta.-1a subunit and methods of use |